SBC / revenue moved 2086 bp lower
SBC / revenue changed -2086 basis points from the comparable as-filed period.
24.80%→3.94%3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SMSI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets increased 15.9%
Current assets changed +15.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$5.9M→$6.8M4 prior comparisons
Current liabilities decreased 25.0%
Current liabilities changed -25.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$6.3M→$4.7M4 prior comparisons
Capital expenditure increased 125.9%
Capital expenditure changed +125.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$27,000→$61,0004 prior comparisons
Free-cash-flow margin moved 3020 bp higher
Free-cash-flow margin changed +3020 basis points from the comparable as-filed period.
-51.92%→-21.72%3 prior comparisons
Operating cash-flow margin moved 3099 bp higher
Operating cash-flow margin changed +3099 basis points from the comparable as-filed period.
-51.31%→-20.32%3 prior comparisons
R&D / revenue moved 3073 bp lower
R&D / revenue changed -3073 basis points from the comparable as-filed period.
62.26%→31.54%3 prior comparisons
Receivables / revenue moved 458 bp lower
Receivables / revenue changed -458 basis points from the comparable as-filed period.
64.86%→60.29%3 prior comparisons
Total assets decreased 12.5%
Total assets changed -12.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$29.6M→$25.9M4 prior comparisons
Revenue decreased 1.8%
Revenue changed -1.8% from the comparable as-filed period.
$4.4M→$4.3M3 prior comparisons
Gross profit increased 8.6%
Gross profit changed +8.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$3.2M→$3.5M3 prior comparisons
Capex / revenue moved 79 bp higher
Capex / revenue changed +79 basis points from the comparable as-filed period.
0.61%→1.41%3 prior comparisons
Trade receivables decreased 8.7%
Trade receivables changed -8.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.9M→$2.6M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.